JPS63192794A - １４α−ヒドロキシ−４−アンドロステン−３，６，１７−トリオン - Google Patents
１４α−ヒドロキシ−４−アンドロステン−３，６，１７−トリオンInfo
- Publication number
- JPS63192794A JPS63192794A JP62024594A JP2459487A JPS63192794A JP S63192794 A JPS63192794 A JP S63192794A JP 62024594 A JP62024594 A JP 62024594A JP 2459487 A JP2459487 A JP 2459487A JP S63192794 A JPS63192794 A JP S63192794A
- Authority
- JP
- Japan
- Prior art keywords
- androstene
- dione
- chloroform
- hydroxy
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 claims description 9
- UKVVNEHFNYKGMX-KIVPVIKRSA-N (8r,9s,10r,13s,14r)-14-hydroxy-10,13-dimethyl-2,7,8,9,11,12,15,16-octahydro-1h-cyclopenta[a]phenanthrene-3,6,17-trione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@]4(O)[C@@H]3CC(=O)C2=C1 UKVVNEHFNYKGMX-KIVPVIKRSA-N 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 30
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 9
- 238000006243 chemical reaction Methods 0.000 abstract description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 abstract description 6
- 239000002904 solvent Substances 0.000 abstract description 6
- 239000000758 substrate Substances 0.000 abstract description 5
- UDHAKZRCGHAPAZ-NFBMXZEVSA-N (6r,8r,9s,10r,13s,14r)-6,14-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,15,16-decahydrocyclopenta[a]phenanthrene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@]4(O)[C@@H]3C[C@@H](O)C2=C1 UDHAKZRCGHAPAZ-NFBMXZEVSA-N 0.000 abstract description 4
- 241000228417 Sarocladium strictum Species 0.000 abstract description 3
- 239000007800 oxidant agent Substances 0.000 abstract description 3
- 239000006228 supernatant Substances 0.000 abstract description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 abstract description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 abstract description 2
- 239000002246 antineoplastic agent Substances 0.000 abstract description 2
- 238000001819 mass spectrum Methods 0.000 abstract description 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 2
- 239000001963 growth medium Substances 0.000 abstract 2
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- OSVMTWJCGUFAOD-KZQROQTASA-N formestane Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1O OSVMTWJCGUFAOD-KZQROQTASA-N 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 102000014654 Aromatase Human genes 0.000 description 5
- 108010078554 Aromatase Proteins 0.000 description 5
- 229960005471 androstenedione Drugs 0.000 description 5
- 210000002826 placenta Anatomy 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000012156 elution solvent Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- AEMFNILZOJDQLW-QAGGRKNESA-N androst-4-ene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 AEMFNILZOJDQLW-QAGGRKNESA-N 0.000 description 3
- AEMFNILZOJDQLW-UHFFFAOYSA-N androstenedione Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 AEMFNILZOJDQLW-UHFFFAOYSA-N 0.000 description 3
- 150000001443 androstenes Chemical class 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- GOPYZMJAIPBUGX-UHFFFAOYSA-N [O-2].[O-2].[Mn+4] Chemical class [O-2].[O-2].[Mn+4] GOPYZMJAIPBUGX-UHFFFAOYSA-N 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- PJMNEPMSGCRSRC-IEVKOWOJSA-N 4-androstene-3,6,17-trione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC(=O)C2=C1 PJMNEPMSGCRSRC-IEVKOWOJSA-N 0.000 description 1
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- GTOWDLHXRPBZKU-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl.ClC(Cl)Cl GTOWDLHXRPBZKU-UHFFFAOYSA-N 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62024594A JPS63192794A (ja) | 1987-02-06 | 1987-02-06 | １４α−ヒドロキシ−４−アンドロステン−３，６，１７−トリオン |
| AT88901462T ATE78825T1 (de) | 1987-02-06 | 1988-02-05 | Neue androst-4-en-3,17-dion-derivate und verfahren zur herstellung. |
| DE8888901462T DE3873200T2 (de) | 1987-02-06 | 1988-02-05 | Neue androst-4-en-3,17-dion-derivate und verfahren zur herstellung. |
| EP88901462A EP0300062B1 (en) | 1987-02-06 | 1988-02-05 | Novel androst-4-ene-3,17-dione derivatives and process for their preparation |
| PCT/JP1988/000114 WO1988005781A1 (en) | 1987-02-06 | 1988-02-05 | Novel androst-4-ene-3,17-dione derivatives and process for their preparation |
| US07/279,596 US4975368A (en) | 1987-02-06 | 1988-09-26 | Novel androst-4-ene-3,17-dione derivatives and method for preparing same |
| US07/555,691 US5079377A (en) | 1987-02-06 | 1990-07-23 | Novel androst-4-ene-3,17-dione derivatives and method for preparing same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62024594A JPS63192794A (ja) | 1987-02-06 | 1987-02-06 | １４α−ヒドロキシ−４−アンドロステン−３，６，１７−トリオン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63192794A true JPS63192794A (ja) | 1988-08-10 |
| JPH0132236B2 JPH0132236B2 (cs) | 1989-06-29 |
Family
ID=12142482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62024594A Granted JPS63192794A (ja) | 1987-02-06 | 1987-02-06 | １４α−ヒドロキシ−４−アンドロステン−３，６，１７−トリオン |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS63192794A (cs) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03294230A (ja) * | 1990-04-12 | 1991-12-25 | Snow Brand Milk Prod Co Ltd | 子宮内膜症治療剤 |
| US5098535A (en) * | 1989-02-07 | 1992-03-24 | Snow Brand Milk Products Co., Ltd. | Process for preparing 14-α-hydroxy-4-androstene-3,6,17-trione |
-
1987
- 1987-02-06 JP JP62024594A patent/JPS63192794A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5098535A (en) * | 1989-02-07 | 1992-03-24 | Snow Brand Milk Products Co., Ltd. | Process for preparing 14-α-hydroxy-4-androstene-3,6,17-trione |
| JPH03294230A (ja) * | 1990-04-12 | 1991-12-25 | Snow Brand Milk Prod Co Ltd | 子宮内膜症治療剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0132236B2 (cs) | 1989-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2304770C (en) | A use of steroidal saponins for the prophylaxis or treatment of dementia, and novel steroidal saponin compounds | |
| JPS6210240B2 (cs) | ||
| WO1996038464A1 (en) | Antimicrobial sterol conjugates | |
| EP0508792A1 (en) | Anti-tumor and anti-psoriatic agents | |
| JPS6150985A (ja) | 新規なカンプトテシン誘導体 | |
| WO1991018003A1 (en) | Antitumor be-13793c derivative | |
| JPH04117394A (ja) | １０位置に置換エチル基を含有する新規のステロイド化合物、それらの製造方法、それらの薬剤としての使用及びそれらを含有する製薬組成物 | |
| JPS63192794A (ja) | １４α−ヒドロキシ−４−アンドロステン−３，６，１７−トリオン | |
| CN1151156C (zh) | 新型呫吨酮化合物、其制备方法和作为药剂的用途 | |
| JP3466527B2 (ja) | 新規なアコニチン系化合物および鎮痛・抗炎症剤 | |
| US5079377A (en) | Novel androst-4-ene-3,17-dione derivatives and method for preparing same | |
| JPH02174793A (ja) | ３β，１７β―ヒドロキシ―置換ステロイド及び関連するステロイド化合物類 | |
| JPS63192796A (ja) | ６β，１４α−ジヒドロキシ−４−アンドロステン−３，１７−ジオン | |
| JP2689144B2 (ja) | ７〆，１１〆−ジヒドロキシーアンドロストー１，４−ジエン−３，１７−ジオン | |
| JPH04368359A (ja) | カプサイシン誘導体又はその酸エステルを有効成分とする鎮痛剤、血管拡張剤 | |
| JP2622712B2 (ja) | ７α，１４α−ジヒドロキシ−アンドロスト−１，４−ジエン−３，１７−ジオン | |
| CN114940695B (zh) | 一种具有抗肿瘤活性的雄诺龙衍生物及其制备方法与应用 | |
| CN103788165B (zh) | 阿糖胞苷胆酸结合物及其制备方法和用途 | |
| JPH01131193A (ja) | １４α−ヒドロキシ−アンドロスト−４−エン−３，６，１７−トリオンのエステル誘導体 | |
| JPH0150716B2 (cs) | ||
| JP2622700B2 (ja) | １５β‐ヒドロキシ‐１９‐ノル‐テストステロン | |
| JPS63192797A (ja) | ６β，１４α−ジヒドロキシ−△↑４−アンドロステン−３，１７−ジオン誘導体 | |
| JPH01229000A (ja) | ２（３―ハイドロキシ―１，３，５（１０）―エストリエン―１７―イル）プロピオン酸の製造法 | |
| JPH01172355A (ja) | 新規リグナン類 | |
| JP4334194B2 (ja) | エクチナサイジン７８６およびその取得方法 |